+1 212 446 5943
Leora Ben-Ami is an intellectual property partner in the New York office of Kirkland & Ellis. Her practice includes all areas of technology, including biotechnology, medical devices, pharmaceuticals and chemistry, mechanical devices, and electronics. She has tried many jury trials as lead counsel and has extensive appellate experience, including arguing before the U.S. Court of Appeals for the Federal Circuit several times and serving as a law clerk there.
Before joining Kirkland, Leora represented Genentech and Astellas in Osi, Genentech v. Mylan, in which she successfully defended against Mylan's attempts to launch a generic version of Tarceva. She has tried numerous cases on behalf of Pfizer including, most recently, Pfizer v. Teva Pharmaceuticals USA, a case in which she successfully defended Pfizer's patents on Celebrex®.
Leora's work has been recognized by The American Lawyer, which named her one of "45 Under Forty-Five: The Rising Stars of the Private Bar," and The National Law Journal, which featured her jury trial verdict on behalf of ARIAD Pharmaceuticals against Eli Lilly in its annual "Defense Hot List." She has also been recognized by Chambers USA, America's Leading Lawyers for Business, Legal 500 U.S., PLC Global Counsel, The International Who's Who of Life Sciences Lawyers and Intellectual Asset Management (IAM) Life Sciences 250 – The World's Leading Life Sciences Lawyers.
Leora frequently speaks at conferences and seminars on patent law, having spoken at the PLI, the New Jersey Intellectual Property Association, the Sedona Conference and many others, and has published widely on intellectual property issues. Leora has also participated in legal education, having been the only practitioner on a panel with three federal judges to create a video on Markman hearings in the biotechnology area for the education of the federal judiciary.
Prior to joining Kirkland, Leora was a partner at Kaye Scholer, where she was co-chair of the intellectual property practice and a member of the executive committee. Earlier, Leora was a partner at Clifford Chance, where she was chair of the global intellectual property group and a member of that firm's board.
Last Updated 27th July 2017